With Many More COVID-19 Vaccine Changes Ahead, ACIP Expecting Fewer Public Meetings

 
• By Derrick Gingery
Transparency sign
CDC expects to bypass the ACIP more often when iterative changes to the COVID-19 vaccine EUAs and BLAs are made. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers